Truvestments Capital’s Steris STE Stock Holding History

Truvestments Capital’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12	Closed	-$2.65K	–	1277
2026 Q1	$2.65K	Hold	12	–	–	﹤0.01%	977
2025 Q4	$3.04K	Hold	12	–	–	﹤0.01%	859
2025 Q3	$2.97K	Buy	+12	New	+$2.87K	﹤0.01%	893
2025 Q1	–	Sell	-12	Closed	-$2.47K	–	1147
2024 Q4	$2.47K	Buy	+12	New	+$2.63K	﹤0.01%	809

Other funds holding STE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Truvestments Capital's STE Position: Q2 2026 in Review

Truvestments Capital sold out of Steris (STE) in Q2 2026, closing a stake of 12 shares — an estimated $2.65K sold.

Truvestments Capital first reported a position in STE in Q4 2024 and held it in 4 quarters. The position peaked at $3.04K in Q4 2025. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

Truvestments Capital reported no remaining Steris position as of Q2 2026 after selling out during the quarter.
Truvestments Capital sold 12 Steris shares in Q2 2026, an estimated $2.65K.
Truvestments Capital first reported a position in Steris in Q4 2024 and held it in 4 quarters.
Truvestments Capital's Steris position peaked at $3.04K in Q4 2025.
835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.